Zoetis, Inc. (ZTS)
80.04
+0.45
(+0.57%)
USD |
NYSE |
Oct 20, 16:00
79.97
-0.07
(-0.09%)
Pre-Market: 07:25
Zoetis Research and Development Expense (TTM) : 722.00M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 722.00M |
| March 31, 2026 | 715.00M |
| December 31, 2025 | 697.00M |
| September 30, 2025 | 684.00M |
| June 30, 2025 | 681.00M |
| March 31, 2025 | 686.00M |
| December 31, 2024 | 686.00M |
| September 30, 2024 | 674.00M |
| June 30, 2024 | 659.00M |
| March 31, 2024 | 634.00M |
| December 31, 2023 | 614.00M |
| September 30, 2023 | 588.00M |
| June 30, 2023 | 570.00M |
| March 31, 2023 | 559.00M |
| December 31, 2022 | 539.00M |
| September 30, 2022 | 529.00M |
| June 30, 2022 | 527.00M |
| March 31, 2022 | 512.00M |
| December 31, 2021 | 508.00M |
| September 30, 2021 | 503.00M |
| June 30, 2021 | 483.00M |
| March 31, 2021 | 474.00M |
| December 31, 2020 | 463.00M |
| September 30, 2020 | 462.00M |
| June 30, 2020 | 462.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 462.00M |
| December 31, 2019 | 457.00M |
| September 30, 2019 | 450.00M |
| June 30, 2019 | 446.00M |
| March 31, 2019 | 437.00M |
| December 31, 2018 | 432.00M |
| September 30, 2018 | 417.00M |
| June 30, 2018 | 405.00M |
| March 31, 2018 | 389.00M |
| December 31, 2017 | 382.00M |
| September 30, 2017 | 380.00M |
| June 30, 2017 | 374.00M |
| March 31, 2017 | 376.00M |
| December 31, 2016 | 376.00M |
| September 30, 2016 | 377.00M |
| June 30, 2016 | 378.00M |
| March 31, 2016 | 374.00M |
| December 31, 2015 | 364.00M |
| September 30, 2015 | 379.00M |
| June 30, 2015 | 381.00M |
| March 31, 2015 | 389.00M |
| December 31, 2014 | 396.00M |
| September 30, 2014 | 393.00M |
| June 30, 2014 | 393.00M |
| March 31, 2014 | 396.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 14.60B |
| Merck & Co., Inc. | 27.26B |
| Pfizer Inc. | 10.82B |
| Phibro Animal Health Corp. | -- |
| Bristol Myers Squibb Co. | 9.548B |